Governance inseparability and the evolution of US biotechnology industry

被引:32
|
作者
Argyres, NS
Liebeskind, JP
机构
[1] Boston Univ, Sch Management, Boston, MA 02215 USA
[2] Univ So Calif, Marshall Sch Business, Los Angeles, CA 90089 USA
关键词
governance; transaction costs; industry evolution;
D O I
10.1016/S0167-2681(01)00202-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper explores mechanisms through which a party's choice of governance mode for a focal transaction is constrained by the governance choices it made for other, prior transactions. We argue that this condition of "governance inseparability" plays an important role in determining the differential organizational costs incurred by various firms when under-taking the same new activity, and is therefore important for theories aimed at predicting what kinds of firms will undertake such an activity. We develop these arguments by showing how governance inseparability conditions help explain the persistent fragmentation of the US biotechnology industry. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 219
页数:23
相关论文
共 50 条
  • [1] Evolution and governance of the biotechnology and pharmaceutical industry of China
    Wang, Kai
    Hong, Jin
    Marinova, Dora
    Zhu, Liang
    [J]. MATHEMATICS AND COMPUTERS IN SIMULATION, 2009, 79 (09) : 2947 - 2956
  • [2] Analysis on the Evolution and Governance of the Biotechnology Industry of China
    Wang, Kai
    Zhu, Liang
    Hong, Jin
    Marinova, Dora
    [J]. MODSIM 2007: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: LAND, WATER AND ENVIRONMENTAL MANAGEMENT: INTEGRATED SYSTEMS FOR SUSTAINABILITY, 2007, : 2693 - 2699
  • [3] The state of the US biotechnology industry
    Bullock, WO
    Dibner, MD
    [J]. TRENDS IN BIOTECHNOLOGY, 1995, 13 (11) : 463 - 467
  • [4] The US biotechnology industry: industry dynamics and policy
    Bagchi-Sen, S
    Smith, HL
    Hall, L
    [J]. ENVIRONMENT AND PLANNING C-GOVERNMENT AND POLICY, 2004, 22 (02): : 199 - 216
  • [5] Trust Formation in University-Industry Collaborations in the US Biotechnology Industry: IP Policies, Shared Governance, and Champions
    Bstieler, Ludwig
    Hemmert, Martin
    Barczak, Gloria
    [J]. JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 2015, 32 (01) : 111 - 121
  • [6] The evolution of the biotechnology industry in Germany
    Müller, C
    [J]. TRENDS IN BIOTECHNOLOGY, 2002, 20 (07) : 287 - 290
  • [7] The inseparability of religion and politics in the neoconservative critique of biotechnology
    Bibbee, Jeffrey R.
    Viens, A. M.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2007, 7 (10): : 18 - 20
  • [8] The evolution of the pharmaceutical-biotechnology industry
    Gottinger, Hans-Werner
    Umali, Celia L.
    [J]. BUSINESS HISTORY, 2008, 50 (05) : 583 - 601
  • [9] BIOTECHNOLOGY INDUSTRY CALLS FOR ACTIVE US ROLE
    MARWICK, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09): : 648 - 648
  • [10] Ingredients in the early development of the US biotechnology industry
    Prevezer, M
    [J]. SMALL BUSINESS ECONOMICS, 2001, 17 (1-2) : 17 - 29